Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

June 05, 2013

AbbVie Inc. et al v. Dr. Reddy's Laboratories Ltd. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 06, 2013

    AbbVie Hits Dr. Reddy's With IP Suit Over Generic Zemplar

    Pharmaceuticals maker AbbVie Inc. on Wednesday accused Dr. Reddy's Research Laboratories Ltd. of infringing three drug patents by seeking approval for a generic version of the hyperactive-thyroid medication Zemplar, according to a suit filed in Delaware federal court.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login